课题基金 / 基金详情

ACTG 341: PATHOGENESIS OF MAC DISEASE IN ADVANCED HIV 1 & HAART IMPAC

ACTG 341: PATHOGENESIS OF MAC DISEASE IN ADVANCED HIV 1 & HAART IMPAC
ACTG 341:晚期 HIV 1 中 MAC 疾病的发病机制
批准号:
6265120
负责人:
MITCHELL GOLDMAN
金额:
$0.04万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MITCHELL GOLDMAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine if tissue infection with MAC occurs prior to sustained bacteremia by obtaining bone marrow biopsies and blood for quantitative cultures from subjects at high risk for DMAC. To examine the relatioship between immune dysregulation and MAC disease by identifying immune profiles correlated with risk for MAC disease. To determine whether the abnormalities in immune cell populations and functions found in MAC- infected subjects and in asymptomatic subjects with low CD4+ counts can be reversed by HAART. To evaluate the relationship between changes in HIV RNA levels after HAART and changes in relevant immune parameters. To evaluate the relationships between baseline plasma HIV-1 RNA levels, relevant immune function abnormalities, and MAC infection status. To evaluate the diagnostic utility of rapid and potentially more sensitive new MAC detection methods by correlation with quantitative cultures of blood and bone marrow. To examine the incidence of intestinal and respiratory colonization of subjects with DMAC and compare the strain identities and virulence properties of colonizing strain(s) with MAC isolate(s) obtained from blood and bone marrow.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Dysfunction Due to HIV-1 Protease Inhibitors
ADULT AIDS CLINICAL TRIALS UNIT
ADULT AIDS CLINICAL TRIALS UNIT
ADULT AIDS CLINICAL TRIALS UNIT